Get access to our best features
Get access to our best features
Published 12 days ago

Take-at-home brain cancer treatment for children will soon be available on NHS

  • A new targeted drug therapy for brain tumors in children, dabrafenib with trametinib, approved by NICE, will now be available through the NHS for those aged 1 to 7 with specific genetic mutations.
  • This treatment offers a more effective and less harmful option than standard chemotherapy, with studies showing it can halt tumor growth for an average of 24.9 months, compared to 7.2 months with chemotherapy.
  • The therapy targets proteins from the mutated gene causing tumor growth, can be administered at home, and is approved for both low-grade and high-grade gliomas with the BRAF V600E mutation.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left
50% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)